Today is Rare Disease day, and since GIST is a rare disease we felt it important to remind everyone to take action. The Life Raft Group works hard to advocate for & support our members and their loved ones, but we need your help.
The Food and Drug Administration, in a much-anticipated announcement for Gastrointestinal Stromal Tumor patients, has approved Bayer Pharmaceutical's drug, Stivarga, for use as a third-line treatment for advanced GIST.
Communication is a two-way street, but unfortunately that is not always the case when finding ways to research rare disease. Sharing of data by researchers does not happen as easily, or as often as you [...]
A GIST Clinic has been announced by the National Institutes of Health. The upcoming "Pediatric and wildtype GIST Clinic" at the NIH is scheduled for June 27th-28th, 2013. There are spots available for the [...]
Add some joy to your life with these Top Ten Valentines Day Romance Tips Janeen with her husband, Larry. Valentine’s Day is a day of love, a day to show that special someone [...]
Dr. Alex Reimann is a leading naturopathic physician. She has devoted her life to cancer patients and others in need.
A recent study at Stanford University School of Medicine shows that an antibody slows GIST growth. The study shows that the antibody binds itself to the surface of a GIST Tumor and causes the growth of cancer cells to slow in the mice they tested.
Treatment guidelines for GIST are established by experts to ensure that patients receive adequate care and appropriate therapies.
Today is World Cancer Day, what are you doing to celebrate? Keep reading to learn how you can make a difference.
Resecting GIST tumors may improve survival rates. Surgically removing residual gastrointestinal stromal tumors in patients who respond to imatinib therapy